Nuvalent NUVL
NUVL
$123.96 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Nuvalent (NUVL) Share-based Compensation (2020 - 2026)

Nuvalent's (NUVL) quarterly Share-based Compensation came in at $226.2 million in Q1 2026, up 28245.86% YoY from N/an in Q1 2025, and up 940.77% on a QoQ basis from $21.7 million in Q4 2025.

Analysis

Nuvalent (NUVL) Share-based Compensation (2020 - 2026) Analysis & Trends

Nuvalent (NUVL) has 7 years of Share-based Compensation data on file, last reported at $226.2 million in Q1 2026.

  • Quarterly Share-based Compensation rose 28245.86% year-over-year to $226.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $226.2 million (up 1832.14% YoY) and the FY2025 annual result came in at $170.4 million, up 17.92% from the prior year.
  • Share-based Compensation rose to $226.2 million in Q1 2026, from $21.7 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $226.2 million in Q1 2026 to a low of -$44.4 million in Q4 2024.
  • A 5-year average of $19.4 million and a median of $6.9 million in 2023 frame the typical range for Share-based Compensation.
  • Annual changes were most pronounced in 2024 — Share-based Compensation tumbled 693.34% — and 2026, when it surged 28245.86%.
  • Tracing NUVL's Share-based Compensation over 5 years: stood at $3.0 million in 2022, then surged by 148.26% to $7.5 million in 2023, then plunged by 693.34% to -$44.4 million in 2024, then surged by 148.91% to $21.7 million in 2025, then surged by 940.77% to $226.2 million in 2026.
  • The last three Share-based Compensation figures came in at $226.2 million (Q1 2026), $21.7 million (Q4 2025), and $22.3 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 277.20 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 41.25 Mn
10 Nuvalent 9.75 Bn 9.75 Bn - 28.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 28.88 Mn
Dec 31, 2025 21.73 Mn
Sep 30, 2025 22.31 Mn
Jun 30, 2025 22.07 Mn
Mar 31, 2025 20.38 Mn
Dec 31, 2024 16.14 Mn
Sep 30, 2024 15.46 Mn
Jun 30, 2024 15.13 Mn
Mar 31, 2024 13.86 Mn
Dec 31, 2023 7.49 Mn
Sep 30, 2023 6.85 Mn
Jun 30, 2023 6.15 Mn
Mar 31, 2023 6.36 Mn
Dec 31, 2022 3.02 Mn
Sep 30, 2022 5.82 Mn
Jun 30, 2022 2.45 Mn
Mar 31, 2022 2.21 Mn
Dec 31, 2021 717,000.00
Sep 30, 2021 1.37 Mn
Jun 30, 2021 2.11 Mn